Younes, Maher Nabil ; Yigitbasi, Orhan Gazi ; Park, Young Wook ; Kim, Sun-Jin ; Jasser, Samar A. ; Hawthorne, Valerie Stone ; Yazici, Yasemin Dakak ; Mandal, Mahitosh ; Bekele, Benjamin Nebiyou ; Bucana, Corazon D. ; Fidler, Isaiah J. ; Myers, Jeffrey N. (2005) Antivascular therapy of human follicular thyroid cancer experimental bone metastasis by blockade of Epidermal Growth Factor Receptor and Vascular Growth Factor Receptor phosphorylation Cancer Research, 65 (11). pp. 4716-4727. ISSN 0008-5472
![]() |
PDF
- Publisher Version
1MB |
Official URL: http://cancerres.aacrjournals.org/content/65/11/47...
Related URL: http://dx.doi.org/10.1158/0008-5472.CAN-04-4196
Abstract
Patients suffering from bone metastases of Follicular Thyroid Carcinoma (FTC) have a poor prognosis because of the lack of effective treatment strategies. The overexpression of Epidermal Growth Factor Receptor (EGFR) associated with increased vascularity has been implicated in the pathogenesis of FTC and subsequent bone metastases. We hypothesized that inhibiting the phosphorylation of the EGFR and Vascular Endothelial Growth Factor Receptor (VEGFR) by AEE788, a dual tyrosine kinase inhibitor of EGFR and VEGFR, in combination with paclitaxel would inhibit experimental FTC bone lesions and preserve bone structure. We tested this hypothesis using the human WRO FTC cell line. In culture, AEE788 inhibited the EGF-mediated phosphorylation of EGFR, VEGFR2, mitogen-activated protein kinase and Akt in culture. AEE788, alone and in combination with paclitaxel, inhibited cell growth and induced apoptosis. When WRO cells were injected into the tibia of nude mice, tumor and endothelial cells within the lesions expressed phosphorylated EGFR, VEGFR, Akt and mitogen-activated protein kinase that were inhibited by the oral administration of AEE788. Therapy consisting of orally given AEE788 and i.p. injected paclitaxel induced a high level of apoptosis in tumor-associated endothelial cells and tumor cells with the inhibition of tumor growth in the bone and the preservation of bone structure. Collectively, these data show that blocking the phosphorylation of EGFR and VEGFR with AEE788 combined with paclitaxel can significantly inhibit experimental human FTC in the bone of nude mice.
Item Type: | Article |
---|---|
Source: | Copyright of this article belongs to American Association for Cancer Research. |
ID Code: | 112930 |
Deposited On: | 09 May 2018 10:54 |
Last Modified: | 09 May 2018 10:54 |
Repository Staff Only: item control page